Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Pacs Group Earnings Call: Key Takeaways

PACS Group delivered strong Q2 2026 results with 9.1% revenue growth and 25% adjusted EBITDA growth, driven by occupancy gains and successful facility turnarounds.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthTotal revenue up 9.1% to $1.43B; same-store SNF revenue up 5.8%.
Mgmt ConfidenceHigh confidence in momentum, increasing full-year revenue and EBITDA guidance ranges.
Demand VisibilityStrong occupancy at 90.4% total; mature facilities at 93.8% occupancy.
Margin TrendsAdjusted EBITDA margin expanded 150 basis points year-over-year to 11.7%.
Op. LeverageRevenue growth of 9.1% outpaced total operating expense growth of 7.3%.
Pricing PowerSkilled mix improved 100 bps to 30%; Medicaid rates up 3%.
Vol vs PriceGrowth driven by 180 bps occupancy increase and 100 bps mix improvement.
Segment GrowthMature facilities (184) lead with 93.8% occupancy and 31.9% skilled mix.
New ClientsAcquired 20 Texas facilities from Eduro; 14 more pending in Q3/Q4.
Capex & DebtDeployed $104.3M for real estate; net leverage ultra-low at 0.1x.
RegulatoryOngoing government investigations; material weaknesses expected to be remediated by year-end.
CommentaryEmphasized 'virtuous cycle' where high clinical quality (83.6% 4/5 stars) drives financial success.
New LaunchesExpanded into 17 states with 324 facilities and 35,631 total beds.

Growth

Revenue reached $1.43 billion; same-store occupancy rose 150 bps to 90.6%.

Outlook

Raised FY2026 revenue guidance to $5.75B-$5.85B and adjusted EBITDA to $640M-$660M.

Risks

Management provided vague timelines for resolving ongoing government investigations and material internal control weaknesses.

Source

The company's earnings call, NYSE: PACS, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Pacs Group, Inc.: key numbers

Share price
$49.00Close, Nov 16
Market cap
$7.78B
Shares outstanding
158.72MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Skilled Nursing Care FacilitiesSIC 8051

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Pacs Group, Inc.

All →
6:01 PM ET Form 4
Insider Selling

Pacs Group President & COO Joshua Jergensen Sells $2M of Stock

Joshua Jergensen, President & COO, sold 40,000 shares of Pacs Group, Inc. at $49.01 to $50.74 a share (average $50.11) in 3 transactions, worth $2M in total on Nov 11, 2026. Shares held after the trade: 2,416,320 (-0.1%).

Value
$2M
Shares
40,000
Average price
$50.11
Role
President & COO
Holding change
-0.1%
Trade date
Nov 11, 2026
6:04 PM ET Form 4
Insider Selling

Pacs Group Co-Founder, CEO & Chairman Jason Hulse Murray Sells $974K of Stock

Jason Hulse Murray, Co-Founder, CEO & Chairman, sold 19,235 shares of Pacs Group, Inc. at $50.60 to $51.10 a share (average $50.64) in 2 transactions, worth $974K in total on Nov 5, 2026. Shares held after the trade: 53,934,866 (-0.0%).

Value
$974K
Shares
19,235
Average price
$50.64
Role
Co-Founder, CEO & Chairman
Holding change
-0.0%
Trade date
Nov 5, 2026
6:02 PM ET Form 4
Insider Selling

Pacs Group CAO Michelle Renee Lewis Sells $159K of Stock

Michelle Renee Lewis, CAO, sold 3,172 shares of Pacs Group, Inc. at $50.06 a share, worth $159K in total on Nov 4, 2026. Shares held after the trade: 340,338 (-0.9%).

Value
$159K
Shares
3,172
Price
$50.06
Role
CAO
Holding change
-0.9%
Trade date
Nov 4, 2026
6:01 PM ET Form 4
Insider Selling

Pacs Group Co-Founder, CEO & Chairman Jason Hulse Murray Sells $11.1M of Stock

Jason Hulse Murray, Co-Founder, CEO & Chairman, sold 225,296 shares of Pacs Group, Inc. at $45.94 to $51.35 a share (average $49.21) in 10 transactions, worth $11.1M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 53,954,101 (-0.0%).

Value
$11.1M
Shares
225,296
Average price
$49.21
Role
Co-Founder, CEO & Chairman
Holding change
-0.0%
Trade date
Nov 2, 2026 to Nov 4, 2026
6:00 PM ET Form 4
Insider Selling

Pacs Group Insider Mark Hancock Sells $9.42M of Stock

Mark Hancock sold 186,696 shares of Pacs Group, Inc. at $50.38 to $51.44 a share (average $50.45) in 2 transactions, worth $9.42M in total on Nov 4, 2026. Shares held after the trade: 53,318,884 (-0.0%).

Value
$9.42M
Shares
186,696
Average price
$50.45
Holding change
-0.0%
Trade date
Nov 4, 2026
4:17 PM ET 10-Q
Financial Results ▶ Call

Pacs Group Q3 2026 Results: Net Income $60.8M, Up 16.1% YoY

PACS Group, Inc. reported total assets of $5.9 billion as of September 30, 2026, with 158,723,533 shares of common stock outstanding. The company is classified as an accelerated filer and an emerging growth company, operating primarily in the healthcare facility sector with significant geographic concentration in California.

Key figure
Net income $60.8M · +16.1% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.